CPT1A is regulated by c-MYC or AMPK in breast cancer, and promotes breast cancer metastasis or therapeutic resistance through several oncogenic signaling pathways, such as VEGF, ERK and Src pathways [25–27, 29, 42]. The gene discussed is MYC; the disease is breast carcinoma.